PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy

被引：0
|
作者：
Mathur, Sandeep [1 ]
Johnson, Anjana [2 ]
Deo, S. V. S. [1 ]
Gogia, Ajay [1 ]
Kahol, Shruti [1 ]
Jain, Deepali [1 ]
Iyer, Venkateswaran [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
[2] All India Inst Med Sci, Delhi, India
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
214
引用
收藏
页码：208 / 209
页数：2
相关论文
共 50 条
  • [31] Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes
    DiNome, Maggie L.
    Orozco, Javier I. J.
    Matsuba, Chikako
    Manughian-Peter, Ayla O.
    Ensenyat-Mendez, Miquel
    Chang, Shu-Ching
    Jalas, John R.
    Salomon, Matthew P.
    Marzese, Diego M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3344 - 3353
  • [32] Clinicopathological features of triple-negative breast cancer in Taiwanese women
    Kuo Yao-Lung
    Chen Dar-Ren
    Chang Tsai-Wang
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (05) : 500 - 505
  • [33] Computational scoring of tumor infiltrating lymphocytes in triple-negative breast cancer
    Amgad, M.
    Sarkar, A.
    Srinivas, C.
    Redman, R.
    Ratra, S.
    Bechert, C. J.
    Calhoun, B. C.
    Mrazeck, K.
    Kurkure, U.
    Cooper, L. A.
    Barnes, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer
    Ilenic, Petra
    Herman, Ajda
    Langerholc, Erik
    Gazic, Barbara
    Seruga, Bostjan
    JOURNAL OF BONE ONCOLOGY, 2024, 44
  • [35] CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression
    Boudin, Laurys
    De Nonneville, Alexandre
    Finetti, Pascal
    Guittard, Geoffrey
    Nunes, Jacques A.
    Birnbaum, Daniel
    Mamessier, Emilie
    Bertucci, Francois
    CANCERS, 2022, 14 (14)
  • [36] PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy
    Bertucci, Francois
    Finetti, Pascal
    Colpaert, Cecile
    Mamessier, Emilie
    Parizel, Maxime
    Dirix, Luc
    Viens, Patrice
    Birnbaum, Daniel
    van Laere, Steven
    ONCOTARGET, 2015, 6 (15) : 13506 - 13519
  • [37] Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy
    Minoru Miyashita
    Hironobu Sasano
    Kentaro Tamaki
    Monica Chan
    Hisashi Hirakawa
    Akihiko Suzuki
    Hiroshi Tada
    Go Watanabe
    Noriko Nemoto
    Saki Nakagawa
    Takanori Ishida
    Noriaki Ohuchi
    Breast Cancer Research and Treatment, 2014, 148 : 525 - 534
  • [38] Tumor-infiltrating CD8+and FOXP3+lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy
    Miyashita, Minoru
    Sasano, Hironobu
    Tamaki, Kentaro
    Chan, Monica
    Hirakawa, Hisashi
    Suzuki, Akihiko
    Tada, Hiroshi
    Watanabe, Go
    Nemoto, Noriko
    Nakagawa, Saki
    Ishida, Takanori
    Ohuchi, Noriaki
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 525 - 534
  • [39] Triple negative breast cancers: PDL1 expression in neoplastic and inflammatory cells
    Sahin, H.
    Ercetin, S. Y.
    Ugurlu, U.
    Gulluoglu, B.
    Aribal, E.
    Kaya, H.
    VIRCHOWS ARCHIV, 2017, 471 : S306 - S306
  • [40] Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancer
    Schaefer, Sarah Alexandra
    Huelsewig, Carolin
    Barth, Peter
    von Wahlde, Marie-Kristin
    Tio, Joke
    Kolberg, Hans-Christian
    Bernemann, Christof
    Blohmer, Jens-Uwe
    Kiesel, Ludwig
    Kolberg-Liedtke, Cornelia
    FUTURE ONCOLOGY, 2019, 15 (16) : 1921 - 1938
12345